The NF-κB pathway has been investigated in RSL3-induced ferroptosis in glioblastoma cells, in which it activated the NF-κB pathway, increased lipid ROS levels, and decreased the expression of ferroptosis-related proteins (GPX4, ATF4, and SLC7A11/xCT). The gene discussed is NFKB1; the disease is glioblastoma.